BACKGROUND Persons with schizophrenia may face barriers to high quality primary care due to communication difficulties, cognitive impairment, lack of social support, and fragmentation of healthcare delivery services. As a result, this group may be at high risk for ambulatory care sensitive (ACS) hospitalizations, defined as hospitalizations potentially preventable by timely primary care. The go...

Background. There is evidence that patients with schizophrenia suffer from decline in working memory performance with consequences for psychosocial outcome. Objective. To evaluate the efficacy of a computerized working memory training program (BrainStim) in patients with chronic schizophrenia. Methods. Twenty-nine inpatients with chronic schizophrenia were assigned to either the intervention gr...

OBJECTIVE There has been consistent evidence for a lower incidence and milder course of schizophrenia in women, yet there have been very few investigations of sex differences in brain function in this disorder. This study used a new high-temporal-resolution measure of functional brain connectivity to test the prediction that female patients would show relatively greater inter- and intrahemisphe...

BACKGROUND Schizophrenia patients have difficulty mastering even rote procedural tasks in rehabilitation settings. Although most studies demonstrate intact procedural learning in schizophrenia, recent findings demonstrate that a critical component of procedural learning is dependent on sleep. This study tested the hypothesis that patients with schizophrenia have a deficit in sleep-dependent pro...

OBJECTIVE To investigate the stroke risk and risk factors in patients with chronic schizophrenia. PATIENTS AND METHODS This study was a large-sample, cross-sectional survey. A total of 363 patients with chronic schizophrenia were selected from the Changping Traditional Chinese Medicine Hospital, Beijing, in August 2014. The patients were divided into either stroke group or control group based...

the aim of this study was to evaluate the effects of atorvastatin on negative symptoms in patients with chronic schizophrenia. the study was a prospective, double-blind, 6-week trial. forty patients participated in the study; 19 patients were assigned to the atorvastatin group as well as 21 patients to the placebo group. for assessing negative signs, we used scale for the assessment of negative...

Introduction Schizophrenia is a severe and common psychiatric disorder characterized by disturbed brain development. Brain-derived neurotrophic factor (BDNF) mediates differentiation survival of neurons as well synaptic plasticity during the Several studies have shown decreased serum levels BDNF in chronic, first episode, drug naïve schizophrenia patients. Folate provides substrate for intracel...

Schizophrenia is a chronic severe psychiatric disorder. Antipsychotic medications are highly efficacious modality of treating patients with schizophrenia. Non-adherence to antipsychotic medication critical problem leading increased relapse rate, hospitalization and health care costs. caused by multi-factors might be varied within the globe. Assessing non-adherence influencing factors would help...

Insomnia that could impair our social, personal, psychological, emotional and educational/professional functioning partially or fully is very common among patients of schizophrenia; the schizophrenic symptoms associated with sleep disturbance, exacerbate on withdrawal antipsychotic treatment. It estimated about 80% people psychosis also experience disruptions mostly suffer from chronic insomnia...